Status:
UNKNOWN
Hepatitis B Virus Infection After Liver Transplantation in Children
Lead Sponsor:
Qiu Li
Conditions:
Hepatitis B Infection
Eligibility:
All Genders
Brief Summary
China is a highly prevalent area of hepatitis B virus（HBV） infection, with at least 75 million hepatitis B virus carriers, and 80% of primary hepatocellular carcinoma (HCC) is associated with chronic ...
Eligibility Criteria
Inclusion
- Patients with end-stage liver disease who require liver transplantation
Exclusion
- Children without liver transplantation refer to children;
- Children who are unwilling to participate;
Key Trial Info
Start Date :
July 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03865966
Start Date
July 5 2019
End Date
December 31 2025
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chongqing Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400014